A new study led by Mayo Clinic found that postmenopausal women receiving menopausal hormone therapy lost 35% more weight while taking tirzepatide, a Food and Drug Administration-approved drug for the ...
Everyday Health on MSN
Using GLP-1s for Obesity During Menopause: Benefits and Risks
Learn how GLP-1 medications support weight loss and heart health in perimenopause and postmenopause, plus get tips for ...
ScienceAlert on MSN
Menopause Hormone Therapy Is Not Linked to Dementia Risk, Review Suggests
There is no strong evidence that replenishing hormones after menopause is linked to dementia, according to a sweeping ...
Menopausal hormone replacement therapy (MHT) was once routinely used to relieve symptoms of menopause and protect against ...
Women who use hormone replacement therapy (HRT) for at least a decade before their final period may see a reduced risk of breast cancer, heart attacks, or strokes, according to a new analysis.
Recent studies found that the age of menopause onset can influence metabolic and cardiovascular outcomes. Other research has ...
Everyday Health on MSN
5 health risks women face after menopause
Lower estrogen levels and other changes in your body related to aging can increase your risk of certain health problems. Here ...
HRT does not increase breast cancer risk in BRCA1/BRCA2 variant carriers, with lower incidence in users versus non-users. Estrogen-alone therapy is linked to reduced mortality, while estrogen plus ...
A large 14-year women’s cohort study finds no significant link between age at menopause and developing diabetes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results